- Conditions
- Systemic Mastocytoses, Indolent, Systemic Mastocytoses, Aggressive
- Interventions
- Bezuclastinib
- Drug
- Lead sponsor
- Cogent Biosciences, Inc.
- Industry
- Eligibility
- 18 Years and older
- U.S. locations
- 20
- States / cities
- La Jolla, California • Los Angeles, California • Normal, Illinois + 14 more
Source: ClinicalTrials.gov public record
Updated May 7, 2026 · Synced May 21, 2026, 9:37 PM EDT